TINAVI Medical Technologies Co., Ltd. (688277.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.82B
Enterprise Value6.75B
P/E Ratio-41
PEG Ratio0.88
Price/Sales Ratio32.55
Price/Book Ratio7.76
Enterprise/Revenue32.61
Enterprise/EBITDA-45.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.79
Operating Margin-0.68
AD

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.18

Income Statement

Revenue278.82M
Revenue/Share0.6
Gross Profit156.13M
EBITDA-130.77M
Net Income-182.75M
Diluted EPS-0.41

Balance Sheet

Total Cash208.08M
Total Cash/Share0.46
Total Debt190.38M
Total Debt/Equity0.16
Current Ratio2.83
Book Value Per Share2.61

Price History

52-Week Change43.44
52-Week High29.05
52-Week Low13.05
Moving Average 50 Days19.28
Moving Average 200 Days19.63

Statistics

Average Volume8.98M
Shares Outstanding455.99M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split FactorN/A
Last Split DateN/A
AD